Group B streptococcus is a leading cause of serious neonatal infection. Most neonatal GBS
infections can be prevented through the use of intrapartum antimicrobial prophylaxis in …

To determine risk factors for neonatal group B streptococcal (GBS) disease, a cohort study
was conducted in Atlanta of infants with invasive GBS disease during 1982 and 1983 …

Group B streptococcus (GBS) remains worldwide a leading cause of severe neonatal
disease. Since the end of the 1990s, various strategies for prevention of the early onset …

The burden of early onset neonatal sepsis due to group B Streptococcus (GBS) has declined
substantially over the past 20 years as a result of widespread use of intrapartum antibiotic …

OBJECTIVE: The objective of the study was to evaluate a rapid real-time polymerase chain
reaction (PCR)–based assay for intrapartum detection of group B streptococcus (GBS) …

Context Group B streptococcus is a leading infectious cause of morbidity in newborns and
causes substantial disease in elderly individuals. Guidelines for prevention of perinatal …

Abstract Background: Group B streptococcus (GBS) is an important cause of neonatal
sepsis. Guidelines advise to collect cultures at 35–37 weeks' gestation and to administer …

Please cite this paper as: Daniels J, Gray J, Pattison H, Gray R, Hills R, Khan K on behalf of
the GBS Collaborative Group. Intrapartum tests for group B streptococcus: accuracy and …

Since its emergence 25 years ago, group B streptococcus has become recognized as a
cause of serious illness in newborns, pregnant women, and adults with chronic medical …

Objective To review the evidence in the literature and to provide recommendations on the
management of pregnant women in labour for the prevention of early-onset neonatal group …